Jump to Content Jump to Main Navigation
User Account
  • Sign In to save searches and organize your favorite content.
  • Not registered? Sign up
  • My Content (0)
  • Searches (0)
More
  • Subscriptions
  • Join E-mail List
  • Help
JNCCN
Menu
  • Home
  • Content
    • Current Issue
    • Past Issues
    • Online First
    • Supplements
    • NCCN Meeting Highlights
    • JNCCN In the News
  • COVID-19
  • CE
  • JNCCN 360
  • Author Center
    • Call for Papers
    • Submit a Manuscript
    • Information for Authors
    • Reprints/Permissions
  • About
    • JNCCN
    • Editorial Board
    • Editorial Calendar
    • NCCN
    • Harborside
Search
Close
Advanced Search Help

Volume 4 (2006): Issue 1 (Jan 2006)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
  • Get eTOC Alerts
  • Get Ahead of Print Alerts
  • Citation Alert
  • Where Are We Headed: The Value of Updating Guidelines
    By: Rodger J. Winn
    Pages: 1
  • The CMS 2006 Quality in Oncology Demonstration Project and NCCN Guidelines
    By: William T. McGivney
    Pages: 2
  • Surviving the Perfect Storm: An RVU-Based Model to Evaluate the Continuing Impact of MMA on the Practice of Oncology
    By: David M. Dunning and Thomas A. Paivanas
    Pages: 3–15
  • Acute Myeloid Leukemia Clinical Practice Guidelines in Oncology
    By: Roswell Park Cancer Institute
    Pages: 16
  • Strategies for the Treatment of Acute Promyelocytic Leukemia
    By: Olga Frankfurt and Martin S. Tallman
    Pages: 37–50
  • Non-Transplant Therapy for Older Adults with Acute Myeloid Leukemia
    By: Mikkael A. Sekeres
    Pages: 51–56
  • Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology
    By: Roswell Park Cancer Institute
    Pages: 58
  • Developmental Therapeutics for Myelodysplastic Syndromes
    By: Aung Naing, Lubomir Sokol and Alan F. List
    Pages: 78–82
  • Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
    By: Steven D. Gore
    Pages: 83–90
  • Myelodysplastic Syndromes: Iron Overload Consequences and Current Chelating Therapies
    By: Peter L. Greenberg
    Pages: 91–96
  • Collapse
  • Expand
  • Advertising
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Permissions
  • Disclaimer

© 2019-2020 National Comprehensive Cancer Network

Follow us on: Share Share Share

Powered by:

PubFactory
  • [34.234.223.227]
  • 34.234.223.227
Close
Edit

Character limit 500/500

@!

Character limit500/500